Compass Therapeutics, Inc. · NASDAQ:CMPX
Adage Capital Partners Gp, L.L.C.'s stake in Compass Therapeutics, Inc. fell to 4.36% (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 12, 2025
Adage Capital Partners Gp, L.L.C.'s stake in Compass Therapeutics, Inc. fell to 4.36%, 5,994,810 shares, as a passive investor on Dec 31, 2024. Filed Feb 12, 2025 (Schedule 13G/A).
- Stake
- 4.36%
- Shares
- 5,994,810
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Adage Capital Management, L.P. | 4.36% | 5,994,810 |
| Adage Capital Partners GP, L.L.C. | 0% | 0 |
| Robert Atchinson | 4.36% | 5,994,810 |
| Phillip Gross | 4.36% | 5,994,810 |
Source
Related
- Compass Therapeutics, Inc.
- Adage Capital Partners Gp, L.L.C.
- Compass Therapeutics, Inc. shareholders
- Form 4 · Lerner Neil · Oct 2, 2026
- Form 4 · Lerner Neil · Sep 25, 2026
- Schedule 13G/A · Vivo Opportunity, LLC · Aug 14, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Schedule 13G/A · Bvf Partners L P · May 15, 2026